Ann: Results of MDC July 2022 EGM, page-9

Seemed to be one large seller wanting out coincidentally at EOFY with the inflation news that everyone was doomed which saw it sell down to 4.3c. Since then there has been very little sellers. With 99% of current holders happy with the nasdaq listing and consolidation, i cant see why they would want to sell now, to all time lows. If so, with $15million US, $ 12million R&D nanocelle funding, $5million current cash, totalling approximately $40million cash, can't see it going any lower completing a phase 3 cancer pain cannabis drug which MDC owns the patent for until 2036. Current Market cap is $29million

Compare to MXC with $1.7million cash, constant flip flop, years of even starting a phase 3, with a market cap of $60million..... MDC should be multiples of the value of this company. So how could and why would it go any lower with 23x more cash in bank and so far ahead on the science and clinical front its not funny. DYOR